Abbott Laboratories and AbbVie Named to S&P Dividend Aristocrats Indices

ABBOTT PARK, Ill., Jan. 21, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) has once again been named to the S&P 500 Dividend Aristocrats and S&P High Yield Dividend Aristocrats Indices.

The S&P 500 Dividend Aristocrats comprises companies in the S&P 500 that have increased dividends every year for the past 25 consecutive years. The S&P High Yield Dividend Aristocrats includes companies within the S&P Composite 1500 with 20 straight years of dividend increases. Abbott has increased its dividend payout for 40 consecutive years.

Abbott's former research-based pharmaceutical business, which became the independent biopharmaceutical company AbbVie on Jan. 1, 2013, was also named to both lists based on the history of the combined companies' dividend record.

About Abbott

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

SOURCE Abbott